These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3695637)

  • 1. The effects of differences in state drug product selection laws on pharmacists' substitution behavior.
    Carroll NV; Fincham JE; Cox FM
    Med Care; 1987 Nov; 25(11):1069-77. PubMed ID: 3695637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Variation in State Regulation of Generic Drug and Interchangeable Biologic Substitutions.
    Sacks CA; Van de Wiele VL; Fulchino LA; Patel L; Kesselheim AS; Sarpatwari A
    JAMA Intern Med; 2021 Jan; 181(1):16-22. PubMed ID: 32865564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic substitution and the hospital formulary system.
    Doering PL; McCormick WC; Klapp DL; Russell WL
    Am J Hosp Pharm; 1981 Dec; 38(12):1949-51. PubMed ID: 7325179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'Generic substitution' in New Jersey, 1979-87.
    Culkin TT; Mendell S
    Am Pharm; 1989 Feb; NS29(2):25-30. PubMed ID: 2648782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of economic effects of drug product selection legislation.
    Goldberg T; DeVito CA; Smith D; Stano M; Vidis JS; Moore WE; Dickson WM
    Med Care; 1979 Apr; 17(4):411-9. PubMed ID: 431151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug product selection: legal issues.
    Christensen TP; Kirking DM; Ascione FJ; Welage LS; Gaither CA
    J Am Pharm Assoc (Wash); 2001; 41(6):868-74. PubMed ID: 11765112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic substitution practices in short-term hospitals.
    Doering PL; Klapp DL; McCormick WC; Russell WL
    Am J Hosp Pharm; 1982 Jun; 39(6):1028-32. PubMed ID: 7102686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of drug substitution legislation--implications for continuing education for Michigan pharmacists.
    Moore WE; Goldberg T; Aldridge GW; Vidis JS; DeVito CA; Dickson WM
    Contemp Pharm Pract; 1980; 3(2):100-3. PubMed ID: 10246108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of state-level pharmacist regulations on generic substitution of prescription drugs.
    Song Y; Barthold D
    Health Econ; 2018 Nov; 27(11):1717-1737. PubMed ID: 29992674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaco-legal considerations in the clinical use of decongestants.
    Brushwood DB
    Pharmacotherapy; 1993; 13(6 Pt 2):135S-142S; discussion 143S-146S. PubMed ID: 7507591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reconsidering the scope of US state laws allowing pharmacist substitution of generic drugs.
    Darrow JJ; Chong JE; Kesselheim AS
    BMJ; 2020 Jun; 369():m2236. PubMed ID: 32576554
    [No Abstract]   [Full Text] [Related]  

  • 12. Prescription drug product substitution decision support.
    Manolakis PG
    J Am Pharm Assoc (2003); 2007; 47(3):328-38. PubMed ID: 17510028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacists' and physicians' responses to the South Carolina Product Selection Act of 1978.
    Sumner ED; Karig AW; Hunt HH
    Contemp Pharm Pract; 1982; 5(2):124-9. PubMed ID: 10256911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethical ideology and product confidence: future pharmacists' attitudes toward generic drug substitution.
    Pelton LE; Smith MC
    Health Mark Q; 1991; 8(3-4):181-92. PubMed ID: 10111968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug product selection in Illinois: the first year's experience.
    Stewart JE; Grussing PG; Purohit AA
    Med Care; 1982 Aug; 20(8):831-42. PubMed ID: 7109752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring factors underlying the attitude of community pharmacists to generic substitution: a nationwide study from Poland.
    Drozdowska A; Hermanowski T
    Int J Clin Pharm; 2016 Feb; 38(1):162-70. PubMed ID: 26620450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of countries' pharmacist-patient communication legal requirements on prescription medications and alignment with practice: Comparison of Nordic countries.
    Svensberg K; Sporrong SK; Björnsdottir I
    Res Social Adm Pharm; 2015; 11(6):784-802. PubMed ID: 25698364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacy practice acts: a five-year follow-up.
    Munger MA; Stilling WJ; Gardner SF
    Ann Pharmacother; 1993 May; 27(5):560-5. PubMed ID: 8347902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescription prices under the New York generic substitution law.
    Francetić I; Lasagna L; Weintraub M; Karch FE
    Ann Intern Med; 1980 Mar; 92(3):419-23. PubMed ID: 7356236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of competition on prescription-drug-product substitution.
    Kralewski JE; Pitt L; Dowd B
    N Engl J Med; 1983 Jul; 309(4):213-6. PubMed ID: 6866035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.